Catalyst Wire Dossier Catalyst Wire Dossier

Plant-based seasonal recombinant trivalent VLP influenza vaccine

· Aramis Biotechnologies Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Plant-based seasonal recombinant trivalent VLP influenza vaccine, covering 2026-03-13 to 2026-03-13. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine [Phase 1, Phase 2]

See pricing